RAFARM
DEAD

Serial Number

79283585

Owner

RAFARM AEBE

Filing Date

Jan 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RAFARM Trademark

Serial Number: 79283585

RAFARM is a trademark filed by RAFARM AEBE on January 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

RAFARM AEBE

Korinthou 12

Entity Type: 99

Trademark Details

Filing Date

January 23, 2020

Registration Date

Not Registered

Goods & Services

Dental wax; dietary and nutritional supplements; dietetic foods adapted for medical use; disinfectant bathroom cleaners; disinfectant toilet bowl cleaners; disinfectants for chemical toilets; disinfectants for contact lenses; disinfectants for hygienic purposes; disinfectants for medical instruments; disinfectants for sanitary purposes; disinfecting handwash; fungicides; herbicides; herbicides for agricultural use; herbicides for domestic use; herbicides, insecticides, pesticides and fungicides for home, garden and lawn use and for professional use; material for stopping teeth; medical adhesive tape; medical adhesives for binding wounds; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of iron deficiency; pharmaceutical preparations for the treatment and/or prevention of heart rhythm disorders; pharmaceutical preparations for the treatment and/or prevention of nausea and vomiting; pharmaceutical preparations for the treatment of allergies or allergy symptoms; pharmaceutical preparations for the treatment and/or prevention of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment and/or prevention of infectious diseases; pharmaceutical preparations for treating and/or preventing allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and/or prevention of ocular hypertension or glaucoma; pharmaceutical preparations for the treatment and/or prevention of ocular inflammation or pain; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; otic preparations; ear drops; pharmaceutical products for ophthalmological use; pharmaceutical preparations for wounds; pharmaceutical preparations for kidney diseases; pharmaceutical preparations for the treatment of otic disorders; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, muscle relaxants; pharmaceutical preparations, namely, corticosteroids; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations, namely, anti-bacterials; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations, namely, immunosuppresants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; preparations for destroying parasites; preparations for destroying vermin; sanitary preparations for medical use; self adhesive dressings; veterinary preparations, namely, pain relief medication; medicinal preparations for the treatment of infectious diseases and for use in oncology; antiallergic medicines; medicines for the treatment of gastrointestinal disorders

Advertising; management of the business affairs and commercial functions in the field of pharmaceuticals; business development services in the field of pharmaceuticals; business management; business administration

Pharmaceutical drug development services; pharmaceutical research services; scientific investigations for medical purposes in the field of pharmaceuticals; scientific research in the field of pharmaceuticals; scientific research and development in the field of pharmaceuticals; scientific research and development of new pharmaceutical products for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 18, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 18, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 10, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 22, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 22, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 18, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 18, 2020 ABN2
REFUSAL PROCESSED BY IB
May 23, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 7, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 7, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Apr 24, 2020 MAFR
NON-FINAL ACTION WRITTEN
Apr 23, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 16, 2020 REPR